Literature DB >> 8818689

Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases.

E K Millar1, N K Sharma, A M Lessells.   

Abstract

Sixteen cases of ductal (endometrioid) carcinoma of the prostate are presented. The tumour presents in elderly men (age range 65-87 years) with haematuria or obstructive symptoms. Serum prostate specific antigen may be normal or raised. On cytoscopy, there is often an exophytic lesion in the region of the verumontanum. Histologically, two variants are recognized: papillary and cribriform, of which there were eight cases each. Eight cases consisted of pure ductal carcinoma and seven were mixed, containing a variable proportion of micro-acinar carcinoma. The associated micro-acinar carcinoma had a Gleason score of at least 5. One case of carcinosarcoma with a ductal epithelial component was also included. All cases displayed positive immunohistochemical staining for prostate specific antigen and prostatic acid phosphatase and but were negative for the basal cell marker MA903. The tumour responds well to orthodox micro-acinar carcinoma therapy and appears notably sensitive to hormonal manipulation. Follow-up of the mixed group is restricted to a maximum of 3 years. Of the eight pure cases, five patients are still alive with survival periods of 11, 8, 7, 3 and 1 years. Three patients died of intercurrent disease of which one patient survived 12 years, having received no treatment. This tumour, therefore, can be regarded as having a good prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818689     DOI: 10.1046/j.1365-2559.1996.d01-483.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Proliferative lesions of prostate: a multivariate approach to differential diagnosis.

Authors:  Fernanda de Barros Correia Cavalcanti; Venâncio Avancini Ferreira Alves; Julio Pereira; Cristina T Kanamura; Alda Wakamatsu; Luís Balthazar Saldanha
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

Review 2.  The update of prostatic ductal adenocarcinoma.

Authors:  Tantan Liu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

3.  Variant prostate carcinoma and elevated serum CA-125.

Authors:  Mehmet Asim Bilen; Adriana Reyes; Deb Bhowmick; April Maa; Robert Bast; Louis L Pisters; Sue-Hwa Lin; Christopher J Logothetis; Shi-Ming Tu
Journal:  Can J Urol       Date:  2014-10       Impact factor: 1.344

4.  An 82-year-old Caucasian man with a ductal prostate adenocarcinoma with unusual cystoscopic appearance: a case report.

Authors:  Stavros Sfoungaristos; Ioannis S Katafigiotis; Stavros I Tyritzis; Adamantios Kavouras; Panagiotis Kanatas; Anastasios Petas
Journal:  J Med Case Rep       Date:  2011-01-11

5.  Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.

Authors:  Todd M Morgan; Christopher J Welty; Funda Vakar-Lopez; Daniel W Lin; Jonathan L Wright
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

6.  Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.

Authors:  Amanda H Seipel; Fredrik Wiklund; N Peter Wiklund; Lars Egevad
Journal:  Virchows Arch       Date:  2013-02-27       Impact factor: 4.064

7.  Immunohistochemical profile of ductal adenocarcinoma of the prostate.

Authors:  Amanda H Seipel; Hemamali Samaratunga; Brett Delahunt; Fredrik Wiklund; Peter Wiklund; Johan Lindberg; Henrik Grönberg; Lars Egevad
Journal:  Virchows Arch       Date:  2014-07-25       Impact factor: 4.064

8.  TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.

Authors:  Tamara L Lotan; Antoun Toubaji; Roula Albadine; Mathieu Latour; Mehsati Herawi; Alan K Meeker; Angelo M DeMarzo; Elizabeth A Platz; Jonathan I Epstein; George J Netto
Journal:  Mod Pathol       Date:  2009-01-16       Impact factor: 7.842

9.  Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.

Authors:  Thomas N Eade; Tahseen Al-Saleem; Eric M Horwitz; Mark K Buyyounouski; David Y T Chen; Alan Pollack
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

Review 10.  Optimizing the diagnosis and management of ductal prostate cancer.

Authors:  Weranja Ranasinghe; Daniel D Shapiro; Miao Zhang; Tharakeswara Bathala; Nora Navone; Timothy C Thompson; Bradley Broom; Ana Aparicio; Shi-Ming Tu; Chad Tang; John W Davis; Louis Pisters; Brian F Chapin
Journal:  Nat Rev Urol       Date:  2021-04-06       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.